Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Donald F, Zoz"'
Autor:
Toby M Maher, Michael Kreuter, Vincent Cottin, Susanne Stowasser, Marlies S Wijsenbeek, Yi Liu, Fernando J Martinez, Luca Richeldi, Arata Azuma, Justin M Oldham, Claudia Valenzuela, Maud Gordat, Donald F Zoz
Publikováno v:
BMJ Open Respiratory Research, Vol 10, Iss 1 (2023)
Methods and analysis In this placebo-controlled, double-blind, phase III trial, patients are being randomised in a 1:1:1 ratio to receive 9 mg or 18 mg of BI 1015550 or placebo two times per day over at least 52 weeks, stratified by use of background
Externí odkaz:
https://doaj.org/article/f2486a20e22e430c8654899f00c91a87
Autor:
Steve Jones, Maxine Flewett, Ron Flewett, Sharon Lee, Bill Vick, Milla Thompson, Sabine Pinnetti, Donald F. Zoz, Anna-Maria Hoffmann-Vold, Michael Kreuter, Toby M. Maher
Publikováno v:
ERJ Open Research, Vol 9, Iss 3 (2023)
Background Patient recruitment and retention are a challenge when conducting clinical trials in patients with pulmonary fibrosis, including idiopathic pulmonary fibrosis and other interstitial lung diseases. This study aimed to understand and address
Externí odkaz:
https://doaj.org/article/0ff8c2d7a0a34cf598fc91e5627dd0bf
Autor:
Luca Richeldi, Arata Azuma, Vincent Cottin, Christian Hesslinger, Susanne Stowasser, Claudia Valenzuela, Marlies S Wijsenbeek, Donald F Zoz, Florian Voss, Toby M Maher
Publikováno v:
Journal of Comparative Effectiveness Research, Vol 12, Iss 1 (2022)
What is this summary about? This plain language summary describes the main findings from a trial in people with idiopathic pulmonary fibrosis (also called IPF) that was recently published in the New England Journal of Medicine. IPF is a rare disease
Externí odkaz:
https://doaj.org/article/2eefb79f4d8a4ee6a4bb83784b1ecb51
Autor:
Toby M. Maher, Christina Schlecker, Doreen Luedtke, Sebastian Bossert, Donald F. Zoz, Armin Schultz
Publikováno v:
ERJ Open Research, Vol 8, Iss 4 (2022)
Introduction BI 1015550 is a phosphodiesterase 4 (PDE4) inhibitor that has antifibrotic properties. Phase I and Ic studies were conducted to investigate the safety, tolerability and pharmacokinetics of BI 1015550 in healthy male subjects and patients
Externí odkaz:
https://doaj.org/article/21b9b0816508498c90339a882a036afe
Autor:
Shervin Assassi, Nan Shao, Ziwei Yin, Elizabeth R. Volkmann, Donald F. Zoz, Thomas B. Leonard
Publikováno v:
Medicine. 101(32)
Systemic sclerosis-associated interstitial lung disease (SSc-ILD) is usually detected in a patient known to have SSc but may be diagnosed prior to SSc. We probed an insurance database to investigate documentation of ILD prior to SSc. Using Optum's Cl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4d012170ee8616c8567a061bb35f493
https://pubmed.ncbi.nlm.nih.gov/35960051
https://pubmed.ncbi.nlm.nih.gov/35960051
Autor:
Toby M, Maher, Christina, Schlecker, Doreen, Luedtke, Sebastian, Bossert, Donald F, Zoz, Armin, Schultz
IntroductionBI 1015550 is a phosphodiesterase 4 (PDE4) inhibitor that has antifibrotic properties. Phase I and Ic studies were conducted to investigate the safety, tolerability and pharmacokinetics of BI 1015550 in healthy male subjects and patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cc33ee0552be7587e3a47357d3f4ec9
http://hdl.handle.net/10044/1/100466
http://hdl.handle.net/10044/1/100466
Autor:
David Roofeh, Kevin K Brown, Ella A Kazerooni, Donald Tashkin, Shervin Assassi, Fernando Martinez, Athol U Wells, Ganesh Raghu, Christopher P Denton, Lorinda Chung, Anna-Maria Hoffmann-Vold, Oliver Distler, Kerri A Johannson, Yannick Allanore, Eric L Matteson, Leticia Kawano-Dourado, John D Pauling, James R Seibold, Elizabeth R Volkmann, Simon L F Walsh, Chester V Oddis, Eric S White, Shaney L Barratt, Elana J Bernstein, Robyn T Domsic, Paul F Dellaripa, Richard Conway, Ivan Rosas, Nitin Bhatt, Vivien Hsu, Francesca Ingegnoli, Bashar Kahaleh, Puneet Garcha, Nishant Gupta, Surabhi Khanna, Peter Korsten, Celia Lin, Stephen C Mathai, Vibeke Strand, Tracy J Doyle, Virginia Steen, Donald F Zoz, Juan Ovalles-Bonilla, Ignasi Rodriguez-Pinto, Padmanabha D Shenoy, Andrew Lewandoski, Elizabeth Belloli, Alain Lescoat, Vivek Nagaraja, Wen Ye, Suiyuan Huang, Toby Maher, Dinesh Khanna
Publikováno v:
Rheumatology
Rheumatology, 2023, 62 (5), pp.1877-1886. ⟨10.1093/rheumatology/keac557⟩
Rheumatology, 2023, 62 (5), pp.1877-1886. ⟨10.1093/rheumatology/keac557⟩
Objectives To establish a framework by which experts define disease subsets in systemic sclerosis associated interstitial lung disease (SSc-ILD). Methods A conceptual framework for subclinical, clinical and progressive ILD was provided to 83 experts,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::755d23ee0c80cf18c0d4d04dde5d7062
https://hdl.handle.net/2434/962120
https://hdl.handle.net/2434/962120
Autor:
Donald F. Zoz, Janine Oman, Thomas M. Best, Jonathan P. Parsons, Gary Phillips, John G. Mastronarde, Christopher C. Kaeding
Publikováno v:
Journal of Asthma. 45:845-848
To determine the prevalence of asthma among all varsity athletes in a large National Collegiate Athletic Association (NCAA) Division I program.We retrospectively reviewed the medical records for all varsity athletes at The Ohio State University (OSU)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10846337613ce543cf818cd5a913e486
https://doi.org/10.1080/02770900802379060
https://doi.org/10.1080/02770900802379060
Autor:
John A. Worrell, Dong Sheng Cheng, Cheryl Markin, John A. Phillips, Eric S. White, Joyce E. Johnson, Steve D. Groshong, Jason M. Pritchett, Brittany R. Jones, Jae-Woo Lee, Donald F. Zoz, Rinat Zaynagetdinov, Lisa Lancaster, Peter F. Crossno, Lisa R. Young, Leena Choi, Pierre P. Massion, Otis B. Rickman, Mark P. Steele, Jonathan A. Kropski, Vasiliy V. Polosukhin, James E. Loyd, Joseph F. Solus, Melinda E. McConaha, Joy D. Cogan, William Lawson, Amber L. Degryse, Timothy S. Blackwell, Jonathan D. Kurtis, Lorraine B. Ware, Linda A. Gleaves, Errine T. Garnett, Frank B. McMahon, Daphne B. Mitchell
Publikováno v:
American journal of respiratory and critical care medicine, vol 191, iss 4
Rationale: Asymptomatic relatives of patients with familial interstitial pneumonia (FIP), the inherited form of idiopathic interstitial pneumonia, carry increased risk for developing interstitial lung disease. Objectives: Studying these at-risk indiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90db7a0160f44d6aeaae775e309007dc
https://pubmed.ncbi.nlm.nih.gov/25679101
https://pubmed.ncbi.nlm.nih.gov/25679101
Autor:
Donald F. Zoz, Joyce E. Johnson, Peter F. Crossno, Cheryl Markin, James E. Loyd, Joy D. Cogan, John A. Phillips, William Lawson, Leena Choi, David A. Schwartz, Timothy S. Blackwell, Otis B. Rickman, John A. Worrell, Jason M. Pritchett, Joseph F. Solus, Siva Avula, Lorraine B. Ware
Publikováno v:
C103. PATHOGENESIS, BIOMARKERS, AND RISK FACTORS FOR INTERSTITIAL LUNG DISEASE: FROM BENCH TO BEDSIDE.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aea2318bc09d0a07d25a25650d320160
https://doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a5164
https://doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a5164